Stanley T. Crooke, Chairman and CEO at IONIS PHARMACEUTICALS INC (IONS), sold 46,904 shares at $60.10 ($2.8M) on 2019-02-13, disclosed to the SEC on 2019-02-14.
Open-market sale of $2.8M IONS by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 1,604 | $96K | 3.4% |
| 2 | $60.00 | 5,300 | $318K | 11.3% |
| 3 | $60.10 | 40,000 | $2.4M | 85.3% |
| Total | $60.09 avg | 46,904 | $2.8M | 100% |
| Filing → |
| IONS | SELL | 2020-12-17 | $2.1M | — | Filing → |
| IONS | SELL | 2020-12-09 | $568K | — | Filing → |
| IONS | SELL | 2020-11-30 | $1.3M | — | Filing → |